Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

FSYX Ocular Pressure Adjusting Pump

N.º K: K252455 · 2026-04-30

SolicitanteBalance Ophthalmics, Inc.
Fecha de decisión2026-04-30
Código de productoQQJ
Comité asesorOP
DecisiónSubstantially Equivalent

Resumen del dispositivo

FSYX Ocular Pressure Adjusting Pump is the device name listed in this FDA 510(k) record. The listed applicant is Balance Ophthalmics, Inc.. It received FDA 510(k) clearance on 2026-04-30 under 510(k) number K252455. The device is classified under product code QQJ. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the FSYX Ocular Pressure Adjusting Pump?

FSYX Ocular Pressure Adjusting Pump is a medical device that received FDA 510(k) clearance on 2026-04-30. The listed applicant is Balance Ophthalmics, Inc.. The 510(k) number is K252455.

When did FSYX Ocular Pressure Adjusting Pump receive FDA 510(k) clearance?

FSYX Ocular Pressure Adjusting Pump received FDA 510(k) clearance on 2026-04-30, under 510(k) number K252455.

Who is the listed applicant for FSYX Ocular Pressure Adjusting Pump?

The FDA 510(k) record lists Balance Ophthalmics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FSYX Ocular Pressure Adjusting Pump?

The FDA product code for FSYX Ocular Pressure Adjusting Pump is QQJ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑